Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Modifiable environmental factors in multiple sclerosis.
Managing patients with neurologic disorders who participate in sports activities.
Predicting outcome in clinically isolated syndrome using machine learning.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity.
Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.
Computational modeling of cytokine signaling in microglia.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
Intrathecal Baclofen Dosing Regimens: A Retrospective Chart Review.
Optimizing treatment success in multiple sclerosis.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.
Contrast-Enhanced MR Imaging in Neuroimaging.
Effect of high-dose vitamin d3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
Protein 4.1R attenuates autoreactivity in experimental autoimmune encephalomyelitis by suppressing CD4(+) T cell activation.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Axonal Damage in Pediatric Multiple Sclerosis.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Pages
« first
‹ previous
…
507
508
509
510
511
512
513
514
515
…
next ›
last »